Csenge Advisory Group’s Acadia Healthcare ACHC Stock Holding History

Csenge Advisory Group’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17	Closed	–	–	201
2018 Q3	$0	Buy	+17	New	+$677	﹤0.01%	999

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Csenge Advisory Group's ACHC Position: Q4 2018 in Review

Csenge Advisory Group sold out of Acadia Healthcare (ACHC) in Q4 2018, closing a stake of 17 shares.

Csenge Advisory Group first reported a position in ACHC in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2018.

Csenge Advisory Group reported no remaining Acadia Healthcare position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 17 Acadia Healthcare shares in Q4 2018.
Csenge Advisory Group first reported a position in Acadia Healthcare in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Acadia Healthcare position peaked at $0 in Q3 2018.
254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.